Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Evaluation of a ceiling effect on the association of new resistance development to antipseudomonal beta-lactam exposure in the critically ill.

Teshome BF, Vouri SM, Hampton NB, Kollef MH, Micek ST.

Infect Control Hosp Epidemiol. 2020 Jan 27:1-2. doi: 10.1017/ice.2019.381. [Epub ahead of print] No abstract available.

PMID:
31983358
2.

Clinical epidemiology of carbapenem-resistant gram-negative sepsis among hospitalized patients: Shifting burden of disease?

Britt NS, Ritchie DJ, Kollef MH, Burnham CD, Durkin MJ, Hampton NB, Micek ST.

Am J Infect Control. 2018 Oct;46(10):1092-1096. doi: 10.1016/j.ajic.2018.03.013. Epub 2018 Apr 26.

3.

Importance of Site of Infection and Antibiotic Selection in the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Sepsis.

Britt NS, Ritchie DJ, Kollef MH, Burnham CA, Durkin MJ, Hampton NB, Micek ST.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02400-17. doi: 10.1128/AAC.02400-17. Print 2018 Apr.

4.

Clinical implications for patients treated inappropriately for community-acquired pneumonia in the emergency department.

Micek ST, Lang A, Fuller BM, Hampton NB, Kollef MH.

BMC Infect Dis. 2014 Feb 5;14:61. doi: 10.1186/1471-2334-14-61.

5.

Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study.

Arnold HM, Hollands JM, Skrupky LP, Smith JR, Juang PH, Hampton NB, McCormick S, Reichley RM, Hoban A, Hoffmann J, Micek ST, Kollef MH.

Ann Pharmacother. 2013 Feb;47(2):170-80. doi: 10.1345/aph.1R523. Epub 2013 Jan 22.

PMID:
23341160

Supplemental Content

Loading ...
Support Center